Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor

Journal of Endourology

Volumn 23, Issue 4, 2009, Pages 645-650

  Calestroupat, Jean Patrice ^a   Sanchez Salas, Rafael ^a   Cathelineau, Xavier ^a   Rozet, Francois ^a   Galiano, Marc ^a   Smyth, Gordon ^a   Kasraeian, Ali ^a   Barret, Eric ^a   Vallancien, Guy ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; FEASIBILITY STUDY; FOLLOW UP; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; OPERATION DURATION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERATOCARCINOMA; TESTIS CANCER;

ADULT; DEMOGRAPHY; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; POSTOPERATIVE COMPLICATIONS; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 64749113872     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0423     Document Type: Article

References (32)

1. Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. Ann Oncol 1997;8:531-538.
2. Ehrlich Y, Yossepowitch O, Kedar D, Baniel J. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: A possible indication for limited dissection. BJU Int 2006;97:1221-1224.
3. Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J Clin Oncol 2007;25:5603-5608.
4. Heidenreich A, Thüer D, Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol 2008;53:260-272.
5. Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 1992;148:1907-1910.
6. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987;138:77-82.
7. Stephenson AJ, Sheinfeld J. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 2004;22:225-235.
8. Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP. Post chemotherapy RPLND in patients with elevated markers: Current concepts and clinical outcome. Urol Clin North Am 2007;34:219-225.
9. Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of disease outside modified retroper-itoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 2007;177:937-943.
10. Yoon GH, Stein JP, Skinner DG. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: An update. Urol Oncol 2005; 23:168-177.
11. Beck SDW, Foster RS, Bihrle R, Donohue JP, Einhorn LH. Long-term clinical outcomes for patients with high volume retroperitoneal teratoma undergoing postchemotherapy surgery. J Urol 2007;177:331. Abstract.
12. Carver BS, Stasi J, Bajorin D, Motzer RJ, Bosl GJ, Sheinfeld J. Improved cinical outcome for men with fibrosis at post chemotherapy retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumors. J Urol 2007; 177:330. Abstract.
13. Kaouk JH, Gill IS. Laparoscopic reconstructive urology. J Urol 2003;170:1070-1078.
14. Wittgen CM, Andrus CH, Fitzgerald SD, Baudendistel LJ, Dahms TE, Kaminski DL. Analysis of the hemodynamic and ventilatory effects of laparoscopic cholecystectomy. Arch Surg 1991;126:997-1001.
15. O'Malley C, Cunningham AJ. Physiologic changes during laparoscopy. Anesthesiol Clin North America 2001;19:1-19.
16. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002;60:130-134.
17. Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol 2005;19:683-692.
18. Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A. Long-term results of laparoscopic retroperitoneal lymph node dissection: A single-center 10-year experience. Urology 2004;63:550-555.
19. Maldonado-Valadez R, Schilling D, Anastasiadis AG, Sturm W, Stenzi A. Corvin S. Post-chemotherapy laparoscopic retroperitoneal lymph-node dissection in testis cancer patients. J Endourol 2007;21:1501-1504.
20. Krege S, Beyer J, Souchon R, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 2008;53:497-513.
21. Rassweiler JJ, Seemann O, Henkel TO, Stock C, Frede T, Alken P. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: Indications and limitations. J Urol 1996;156:1108-1113.
22. Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2007;25:4365-4369.
23. Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 2007;110:1235-1240.
24. Romero FR, Wagner A, Brito FA, Muntener M, Lima GC, Kavoussi LR. Refining the laparoscopic retroperitoneal lymph node dissection for testicular cancer. Int Braz J Urol 2006;32:196-201.
25. Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005;23:6149-6156.
26. Stephenson AJ, Hakimi AA, Snyder ME. Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol 2004;171:130-134.
27. Marec-Berard P, Blay JY, Schell M, Buclon M, Demaret C, Ray-Coquard I. Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients. J Clin Oncol 2003;21:4235-4238.
28. Permpongkosol S, Lima GC, Warlick CA, Allaf ME, Var-karakis IM, Bagga HS, Kohanim S, Kavoussi LR. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection: Evaluation of complications. Urology 2007;69: 361-365.
29. Spermon JR, Witjes JA. Case report: The danger of post-chemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. J Endourol 2008;22:1013-1016.
30. Tsivian A, Sidi AA. Port site metastases in urological lapa-roscopic surgery, J Urol 2003;169:1213-1218.
31. Castillo OA, Vitagliano G. Port site metastasis and tumor seeding in oncologic laparoscopic urology. Urology 2008;71: 372-378.
32. Nielsen ME, Lima G, Schaeffer EM, Porter J, Cadeddu JA, Tuerk I, Kavoussi LR. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 2007;70:1168-1172.